Answers are grounded in this paper and cite their sources.
Lithium is an effective maintenance treatment for Bipolar Affective Disorder. However, it is also associated with renal impairment. End-Stage Renal Disease (ESRD) is the most severe form of chronic kidney disease (CKD) and has significant morbidity and mortality. To conduct a systematic review on ESRD incidence in adult patients taking lithium for mood disorders. The search was conducted on EMBASE, MEDLINE, PsycINFO, and CENTRAL for relevant articles. Relevant bibliographies were also searched. Original research in English, reporting on ESRD in adults with affective disorders on lithium, was included. End-stage renal disease was defined as estimated Glomerular Filtration Rate (eGFR) < 15mL/minute/1.73m 2 or renal replacement therapy (RRT). Studies with lithium exposure for a mean duration of less than five years were excluded. Eight retrospective cohort studies were included. Studies were heterogeneous, making direct comparisons difficult. Results showed that ESRD occurs rarely, less than 1% in the absence of a pre-existing renal disease, and typically after decades of lithium exposure. In the presence of chronic kidney disease, discontinuation of lithium after a point of return was not necessarily associated with lower rates of ESRD. However, the trajectory of renal function after discontinuation of lithium remains debatable warranting further prospective studies. There were inconsistent results regarding how confounding factors, such as hypertension and diabetes, contributed to ESRD risk in lithium users. End-stage renal disease is a rare outcome that develops after decades of lithium treatment. The literature on ESRD associated with lithium is limited by the long latency of ESRD, retrospective study designs, and confounding covariates.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: